http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106806948-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-41 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106806948-B |
| titleOfInvention | Application of PI3K/mTOR dual inhibitor |
| abstract | The invention provides a use of a PI3K/mTOR dual inhibitor, a drug-loaded stent and a preparation method thereof, wherein the PI3K/mTOR dual inhibitor is used for preparing a drug for inhibiting vascular intimal hyperplasia, and the PI3K/mTOR dual inhibitor is loaded on a stent body to prepare the drug-loaded stent for inhibiting vascular intimal hyperplasia, and the PI3K/mTOR dual inhibitor has an inhibiting effect on PI3K and mTOR, so that the dual-target effect of a single drug can be exerted, compared with the effect of using a single mTOR inhibitor, the dual-target effect of inhibiting the smooth muscle of a blood vessel is stronger, the vascular intimal hyperplasia is effectively inhibited, and the restenosis rate of the blood vessel is further reduced. |
| priorityDate | 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 290.